norspan 5 mcg/h system transdermalny
mundipharma a/s - buprenorphinum - system transdermalny - 5 mcg/h
norspan 20 mcg/h system transdermalny
mundipharma a/s - buprenorphinum - system transdermalny - 20 mcg/h
norspan 10 mcg/h system transdermalny
mundipharma a/s - buprenorphinum - system transdermalny - 10 mcg/h
normatens 5 mg + 0,5 mg + 0,1 mg tabletki drażowane
bausch health ireland ltd. - clopamidum + dihydroergocristini mesylas + reserpinum - tabletki drażowane - 5 mg + 0,5 mg + 0,1 mg
normapina 5 mg 5 mg tabletki
medicplast polska sp. z o.o. - amlodipinum - tabletki - 5 mg
normapina 10 mg 10 mg tabletki
medicplast polska sp. z o.o. - amlodipinum - tabletki - 10 mg
capsagamma 53 mg kapsaicynoidów w przeliczeniu na kapsaicynę/100 g krem
woerwag pharma gmbh & co. kg - capsici extractum spissum normatum - krem - 53 mg kapsaicynoidów w przeliczeniu na kapsaicynę/100 g
sanohepatic 70 mg sylimaryny w przeliczeniu na sylibininę tabletki powlekane
natur produkt pharma sp. z o.o. - silybi mariani extractum siccum raffinatum et normatum - tabletki powlekane - 70 mg sylimaryny w przeliczeniu na sylibininę
escalar - maść
przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - arnicae chamissonis extractum spissum + hippocastani seminis extractum siccum normatum - maść - -
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - immunoglobuliny ludzkiej normalnej - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - odporne surowicy i immunoglobuliny, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.